Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NAFLD, Non-alcoholic Fatty Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03774511
What this trial is testing

Effects of Exercise on Patients With Nonalcoholic Fatty Liver Disease- A Comparative Randomized Controlled Trial

Who this might be right for
DiabetesNonalcoholic Fatty Liver DiseaseObesity+1 more
Ahlia University 48
Not applicableEnded earlyNCT02345421
What this trial is testing

Identify and Characterize LAL-D Patients in High-risk Populations

Who this might be right for
Lysosomal Acid Lipase Deficiency
Alexion Pharmaceuticals, Inc. 640
Testing effectiveness (Phase 2)Active Not RecruitingNCT05583344
What this trial is testing

Phase 2b Study of GSK4532990 in Adults With NASH

Who this might be right for
Nonalcoholic Fatty Liver DiseaseNon-alcoholic Fatty Liver Disease
GlaxoSmithKline 284
Not applicableStudy completedNCT01100398
What this trial is testing

Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Utilizing Ultrasound and Percutaneous Liver Biopsy

Who this might be right for
Fatty Liver
Brooke Army Medical Center 400
Not applicableActive Not RecruitingNCT04820036
What this trial is testing

A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG)

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)Endoscopic Sleeve GastroplastyNon-alcoholic Fatty Liver Disease (NAFLD)+4 more
Brigham and Women's Hospital 20
Testing effectiveness (Phase 2)Study completedNCT03400163
What this trial is testing

A Sub-study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)

Who this might be right for
Non-Alcoholic Steatohepatitis
Bristol-Myers Squibb 3
Post-approval studies (Phase 4)Study completedNCT02875821
What this trial is testing

Effects of Ipragliflozin on Excessive Fat in Type 2 Diabetes Patients With Non-alcoholic Fatty Liver Disease Treated With Metformin and Pioglitazone

Who this might be right for
Type 2 Diabetes With Non-alcoholic Fatty Liver (NAFLD)
Yonsei University 44
Not applicableUnknownNCT02400099
What this trial is testing

Protein-rich Diet and NAFLD in Bariatric Surgery

Who this might be right for
ObesityNon-alcoholic Fatty Liver Disease
Catholic University of the Sacred Heart 60
Not applicableStudy completedNCT05764811
What this trial is testing

SGLT-2 Inhibitor Effects on Cardiac and Hepatic Metabolic Profiles for the Diabetes Patients Combined With Obesity

Who this might be right for
Fatty Liver Disease
National Cheng-Kung University Hospital 40
Testing effectiveness (Phase 2)Study completedNCT04906421
What this trial is testing

Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Metabolic Dysfunction-assocated Steatohepatitis/ Nonalcoholic Fatty Liver Disease
Sagimet Biosciences Inc. 168
Post-approval studies (Phase 4)Study completedNCT01002547
What this trial is testing

Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Hispanics With Diabetes Mellitus Type 2 (T2DM) and Role of Treatment

Who this might be right for
Nonalcoholic Steatohepatitis
VA Office of Research and Development 105
Not applicableStudy completedNCT03608748
What this trial is testing

Early Detection of Advanced Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver DiseaseLiver Fibrosis
HaEmek Medical Center, Israel 1,000
Testing effectiveness (Phase 2)Study completedNCT02581085
What this trial is testing

Tocotrienol Against the Progression of End Stage Liver Disease

Who this might be right for
End Stage Liver DiseaseNASH - Nonalcoholic SteatohepatitisNAFLD - Nonalcoholic Fatty Liver Disease
Chandan Sen 110
Testing effectiveness (Phase 2)Looking for participantsNCT07308548
What this trial is testing

A Trial to Evaluate the Efficacy, Safety, PK, and PD of HP515 in Non - Alcoholic Fatty Liver Disease ( NASH/MASH )

Who this might be right for
NAFLD (Non-alcoholic Fatty Liver Disease)
Hinova Pharmaceuticals Inc. 80
Not applicableNot Yet RecruitingNCT06097338
What this trial is testing

Quantitative US for Evaluation of Hepatic Steatosis in MAFLD With UDFF

Who this might be right for
Fatty Liver Disease, Nonalcoholic
Qianfoshan Hospital 200
Testing effectiveness (Phase 2)WithdrawnNCT03291249
What this trial is testing

Assessment of the Safety of Foralumab, an Oral Anti-CD3 Antibody, in Patients With NASH and T2DM

Who this might be right for
NASH - Nonalcoholic SteatohepatitisNAFLDT2DM (Type 2 Diabetes Mellitus)
Tiziana Life Sciences LTD
Not applicableActive Not RecruitingNCT05740358
What this trial is testing

Liver Cirrhosis Network Cohort Study

Who this might be right for
CirrhosisCirrhosis, LiverCirrhosis Early+9 more
Northwestern University 1,222
Not applicableStudy completedNCT02383485
What this trial is testing

Nonalcoholic Fatty Liver Disease and Atherosclerotic Risk in Children

Who this might be right for
Overweight and ObesityNon-alcoholic Fatty Liver Disease
Augusta University 175
Not applicableWithdrawnNCT00375349
What this trial is testing

Non Alcoholic Fatty Liver Disease Influence of Statin Therapy

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)
Shaare Zedek Medical Center
Not applicableStudy completedNCT01317576
What this trial is testing

Optimizing the Beneficial Health Effects of Exercise for Diabetes: Focus on the Liver!

Who this might be right for
Diabetes Mellitus, Type 2Non-alcoholic Fatty Liver DiseaseObesity
Bram Brouwers 81
Next Page